Upsurge of kala-azar cases in Southern Sudan requires rapid response
WHO and Gilead sign agreement for enhanced access to visceral leishmaniasis treatment
Call on WHO to lead a network aimed at the control of leishmaniasis
South-East Asia poised to defeat visceral leishmaniasis (kala-azar)
WHO aims to improve access to antileishmanial medicines in affected countries
WHO to implement online epidemiological surveillance for leishmaniasis
New leishmaniasis country profiles based on routine surveillance data
WHO and Gilead Sciences extend collaboration against visceral leishmaniasis
